Pulse Therapeutics, Inc.

United States of America

Back to Profile

1-21 of 21 for Pulse Therapeutics, Inc. Sort by
Query
Aggregations
Jurisdiction
        United States 16
        World 3
        Canada 2
Date
2025 January 1
2024 December 2
2024 November 1
2025 (YTD) 1
2024 4
See more
IPC Class
A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for 14
A61N 2/00 - Magnetotherapy 14
A61B 17/00 - Surgical instruments, devices or methods 10
A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation 10
B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery 10
See more
Status
Pending 4
Registered / In Force 17
Found results for  patents

1.

DELIVERY OF MAGNETIC PARTICLES IN CONJUNCTION WITH THERAPEUTIC AND/OR DIAGNOSTIC AGENTS

      
Application Number 18593397
Status Pending
Filing Date 2024-03-01
First Publication Date 2025-01-16
Owner Pulse Therapeutics, Inc. (USA)
Inventor
  • Kidd, Brian L.
  • Creighton, Francis M.
  • Morris, Sean C.

Abstract

Controlled delivery of magnetic particles (e.g., nanoparticles) in combination with therapeutic, diagnostic and/or theranostic agents is described. The magnetic particles may be delivered through a catheter to a location adjacent a therapeutic and/or diagnostic target or region.

IPC Classes  ?

  • A61N 2/12 - Magnetotherapy using variable magnetic fields obtained by mechanical movement
  • A61B 17/00 - Surgical instruments, devices or methods
  • A61B 17/3207 - Atherectomy devices
  • A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
  • A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
  • A61N 2/00 - Magnetotherapy
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

2.

MAGNETIC-BASED SYSTEMS AND METHODS FOR MANIPULATION OF MAGNETIC PARTICLES

      
Application Number 18510188
Status Pending
Filing Date 2023-11-15
First Publication Date 2024-12-26
Owner PULSE THERAPEUTICS, INC. (USA)
Inventor
  • Creighton, Francis M.
  • Sabo, Michael E.

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one embodiment, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Magnetic nanoparticles are provided having a non-specialized chemical coating facilitating association with a chemical composition by a user before infusion. Systems are provided for delivering a consistent infusion mass of magnetic nanoparticles to a patient.

IPC Classes  ?

  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61B 17/00 - Surgical instruments, devices or methods
  • A61B 17/32 - Surgical cutting instruments
  • A61B 17/3207 - Atherectomy devices
  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
  • H01F 7/02 - Permanent magnets

3.

Magnetically controlled flow generation

      
Application Number 17653939
Grant Number 12171443
Status In Force
Filing Date 2022-03-08
First Publication Date 2024-12-24
Grant Date 2024-12-24
Owner Pulse Therapeutics, Inc. (USA)
Inventor Morris, Sean C.

Abstract

This disclosure generally relates to systems and methods for facilitating flow within vasculature or other body lumens, channels or passages involving a magnetic field generated by an external magnetic control system and/or facilitating clearance of obstructions (e.g., clots, fluid obstructions) within in-dwelling devices (e.g., shunts, drains, conduits, ports, catheters) involving magnetic particles (e.g., nanoparticles, microparticles) controlled by an external magnetic control system (e.g., one or more rotating permanent magnets or an electromagnetic control system).

IPC Classes  ?

  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61B 17/00 - Surgical instruments, devices or methods
  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation

4.

MAGNETIC PARTICLE CONTROL AND VISUALIZATION

      
Application Number 18506673
Status Pending
Filing Date 2023-11-10
First Publication Date 2024-11-21
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.

IPC Classes  ?

  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • A61B 17/00 - Surgical instruments, devices or methods
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61N 2/00 - Magnetotherapy
  • A61N 2/02 - Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
  • A61N 2/06 - Magnetotherapy using magnetic fields produced by permanent magnets
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
  • H01F 7/02 - Permanent magnets

5.

DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS

      
Application Number 18519442
Status Pending
Filing Date 2023-11-27
First Publication Date 2024-10-31
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

A system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator is provided. In one embodiment, the invention relates to the control of magnetic particles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Examples of vascular occlusions targeted by the system include, but are not limited to, atherosclerotic plaques, including fibrous caps, fatty buildup, coronary occlusions, arterial stenosis, restenosis, vein thrombi, arterial thrombi, cerebral thrombi, embolisms, hemorrhages, other blood clots, and very small vessels.

IPC Classes  ?

  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • A61B 17/00 - Surgical instruments, devices or methods
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61N 2/00 - Magnetotherapy
  • A61N 2/02 - Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
  • A61N 2/06 - Magnetotherapy using magnetic fields produced by permanent magnets
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
  • H01F 7/02 - Permanent magnets

6.

Magnetic particle control and visualization

      
Application Number 17302625
Grant Number 11612655
Status In Force
Filing Date 2021-05-07
First Publication Date 2021-11-04
Grant Date 2023-03-28
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.

IPC Classes  ?

  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • H01F 7/02 - Permanent magnets
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61N 2/00 - Magnetotherapy
  • A61N 2/02 - Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
  • A61N 2/06 - Magnetotherapy using magnetic fields produced by permanent magnets
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
  • A61B 17/00 - Surgical instruments, devices or methods

7.

Magnetic particle control and visualization

      
Application Number 16218867
Grant Number 11000589
Status In Force
Filing Date 2018-12-13
First Publication Date 2019-08-22
Grant Date 2021-05-11
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.

IPC Classes  ?

  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • H01F 7/02 - Permanent magnets
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61N 2/00 - Magnetotherapy
  • A61N 2/02 - Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
  • A61N 2/06 - Magnetotherapy using magnetic fields produced by permanent magnets
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
  • A61B 17/00 - Surgical instruments, devices or methods

8.

DELIVERY OF MAGNETIC PARTICLES IN CONJUNCTION WITH THERAPEUTIC AND/OR DIAGNOSTIC AGENTS

      
Application Number US2018062610
Publication Number 2019/108536
Status In Force
Filing Date 2018-11-27
Publication Date 2019-06-06
Owner PULSE THERAPEUTICS, INC. (USA)
Inventor
  • Kidd, Brian, L.
  • Creighton, Francis, M.
  • Sabo, Michael, E.
  • Morris, Sean, C.

Abstract

Controlled delivery of magnetic particles (e.g., nanoparticles) in combination with therapeutic, diagnostic and/or theranostic agents is described. The magnetic particles may be delivered through a catheter to a location adjacent a therapeutic and/or diagnostic target or region.

IPC Classes  ?

  • A61B 17/3207 - Atherectomy devices
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61N 2/06 - Magnetotherapy using magnetic fields produced by permanent magnets
  • A61N 2/10 - Magnetotherapy using magnetic fields produced by permanent magnets applied within the body, e.g. with injected or implanted elements
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

9.

Devices for controlling magnetic nanoparticles to treat fluid obstructions

      
Application Number 16032796
Grant Number 10813997
Status In Force
Filing Date 2018-07-11
First Publication Date 2019-02-07
Grant Date 2020-10-27
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

A system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator is provided. In one embodiment, the invention relates to the control of magnetic particles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Examples of vascular occlusions targeted by the system include, but are not limited to, atherosclerotic plaques, including fibrous caps, fatty buildup, coronary occlusions, arterial stenosis, restenosis, vein thrombi, arterial thrombi, cerebral thrombi, embolisms, hemorrhages, other blood clots, and very small vessels.

IPC Classes  ?

  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61N 2/06 - Magnetotherapy using magnetic fields produced by permanent magnets
  • A61N 2/02 - Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
  • A61N 2/00 - Magnetotherapy
  • A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
  • H01F 7/02 - Permanent magnets
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
  • A61B 17/00 - Surgical instruments, devices or methods

10.

Magnetic particle control and visualization

      
Application Number 15160944
Grant Number 10159734
Status In Force
Filing Date 2016-05-20
First Publication Date 2017-05-11
Grant Date 2018-12-25
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.

IPC Classes  ?

  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • H01F 7/02 - Permanent magnets
  • A61N 2/00 - Magnetotherapy
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61N 2/02 - Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
  • A61N 2/06 - Magnetotherapy using magnetic fields produced by permanent magnets
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
  • A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
  • A61B 17/00 - Surgical instruments, devices or methods

11.

Therapeutic magnetic control systems and contrast agents

      
Application Number 15155386
Grant Number 10029008
Status In Force
Filing Date 2016-05-16
First Publication Date 2017-04-06
Grant Date 2018-07-24
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

A system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator is provided. In one embodiment, the invention relates to the control of magnetic particles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Examples of vascular occlusions targeted by the system include, but are not limited to, atherosclerotic plaques, including fibrous caps, fatty buildup, coronary occlusions, arterial stenosis, restenosis, vein thrombi, arterial thrombi, cerebral thrombi, embolisms, hemorrhages, other blood clots, and very small vessels.

IPC Classes  ?

  • A61N 2/00 - Magnetotherapy
  • H01F 7/02 - Permanent magnets
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
  • A61N 2/02 - Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
  • A61N 2/06 - Magnetotherapy using magnetic fields produced by permanent magnets
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
  • A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
  • A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
  • A61B 17/00 - Surgical instruments, devices or methods

12.

Magnetic-based systems and methods for manipulation of magnetic particles

      
Application Number 14400999
Grant Number 09883878
Status In Force
Filing Date 2013-05-13
First Publication Date 2015-08-20
Grant Date 2018-02-06
Owner Pulse Therapeutics, Inc. (USA)
Inventor
  • Creighton, Francis M.
  • Sabo, Michael
  • Null, Christopher
  • Epplin, Gerard
  • Wachtman, James Christopher

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one embodiment, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Magnetic nanoparticles are provided having a non-specialized chemical coating facilitating association with a chemical composition by a user before infusion. Systems are provided for delivering a consistent infusion mass of magnetic nanoparticles to a patient.

IPC Classes  ?

  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
  • H01F 7/02 - Permanent magnets

13.

Controlling magnetic nanoparticles to increase vascular flow

      
Application Number 14020173
Grant Number 08926491
Status In Force
Filing Date 2013-09-06
First Publication Date 2014-05-15
Grant Date 2015-01-06
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.

IPC Classes  ?

  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
  • A61N 2/00 - Magnetotherapy
  • H01F 7/02 - Permanent magnets
  • A61K 41/00 - Medicinal preparations obtained by treating materials with wave energy or particle radiation

14.

MAGNETIC-BASED SYSTEMS AND METHODS FOR MANIPULATION OF MAGNETIC PARTICLES

      
Application Number US2013040789
Publication Number 2013/173235
Status In Force
Filing Date 2013-05-13
Publication Date 2013-11-21
Owner PULSE THERAPEUTICS, INC. (USA)
Inventor
  • Creighton, Francis, M.
  • Sabo, Michael
  • Null, Christopher
  • Epplin, Gerard
  • Wachtman, James Christopher

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one embodiment, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Magnetic nanoparticles are provided having a non-specialized chemical coating facilitating association with a chemical composition by a user before infusion. Systems are provided for delivering a consistent infusion mass of magnetic nanoparticles to a patient.

IPC Classes  ?

  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61N 2/10 - Magnetotherapy using magnetic fields produced by permanent magnets applied within the body, e.g. with injected or implanted elements
  • A61M 5/142 - Pressure infusion, e.g. using pumps
  • A61B 8/00 - Diagnosis using ultrasonic, sonic or infrasonic waves

15.

Devices for controlling magnetic nanoparticles to treat fluid obstructions

      
Application Number 13505447
Grant Number 08715150
Status In Force
Filing Date 2010-11-02
First Publication Date 2012-12-06
Grant Date 2014-05-06
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

The present invention relates to a system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator. In one aspect, the invention relates to the control of magnetic particles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Examples of vascular occlusions targeted by the system include, but are not limited to, atherosclerotic plaques, including fibrous caps, fatty buildup, coronary occlusions, arterial stenosis, restenosis, vein thrombi, arterial thrombi, cerebral thrombi, embolisms, hemorrhages, other blood clots, and very small vessels.

IPC Classes  ?

  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
  • A61N 2/00 - Magnetotherapy

16.

Methods of controlling magnetic nanoparticles to improve vascular flow

      
Application Number 13485613
Grant Number 08529428
Status In Force
Filing Date 2012-05-31
First Publication Date 2012-11-22
Grant Date 2013-09-10
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.

IPC Classes  ?

  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
  • A61N 2/00 - Magnetotherapy

17.

Magnetic-based methods for treating vessel obstructions

      
Application Number 13471908
Grant Number 08313422
Status In Force
Filing Date 2012-05-15
First Publication Date 2012-09-13
Grant Date 2012-11-20
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.

IPC Classes  ?

  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
  • A61N 2/00 - Magnetotherapy

18.

Magnetic-based systems for treating occluded vessels

      
Application Number 13471871
Grant Number 08308628
Status In Force
Filing Date 2012-05-15
First Publication Date 2012-09-06
Grant Date 2012-11-13
Owner Pulse Therapeutics, Inc. (USA)
Inventor Creighton, Francis M.

Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.

IPC Classes  ?

  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
  • A61N 2/00 - Magnetotherapy

19.

MAGNETOMOTIVE STATOR SYSTEM AND METHODS FOR WIRELESS CONTROL OF MAGNETIC ROTORS

      
Document Number 02777841
Status In Force
Filing Date 2010-11-02
Open to Public Date 2011-05-05
Grant Date 2017-01-17
Owner PULSE THERAPEUTICS, INC. (USA)
Inventor Creighton, Francis M.

Abstract

The present invention relates to a system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator. In one aspect, the invention relates to the control of magnetic particles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Examples of vascular occlusions targeted by the system include, but are not limited to, atherosclerotic plaques, including fibrous caps, fatty buildup, coronary occlusions, arterial stenosis, restenosis, vein thrombi, arterial thrombi, cerebral thrombi, embolisms, hemorrhages, other blood clots, and very small vessels.

IPC Classes  ?

  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61N 2/10 - Magnetotherapy using magnetic fields produced by permanent magnets applied within the body, e.g. with injected or implanted elements
  • H01F 7/06 - ElectromagnetsActuators including electromagnets

20.

MAGNETOMOTIVE STATOR SYSTEM AND METHODS FOR WIRELESS CONTROL OF MAGNETIC ROTORS

      
Document Number 02934401
Status In Force
Filing Date 2010-11-02
Open to Public Date 2011-05-05
Grant Date 2017-01-10
Owner PULSE THERAPEUTICS, INC. (USA)
Inventor Creighton, Francis M.

Abstract

A system for increasing diffusion of a pharmaceutical composition in a body lumen of a subject includes a plurality of individual magnetic rotors, a magnet having a magnetic field and a gradient, and a controller configured to position and rotate the magnetic field and to control the gradient in a manner to cause the individual magnetic rotors to form ensembles in which each individual magnetic rotor generally simultaneously rotates and travels in a same direction, and to cause the ensembles to simultaneously rotate and travel toward a therapeutic target in the body lumen to collectively create hydrodynamic forces that generate turbulence and increase diffusion of a pharmaceutical composition capable of inducing a desired therapeutic effect in the body lumen.

IPC Classes  ?

  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body
  • A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
  • A61N 2/00 - Magnetotherapy
  • H01F 7/06 - ElectromagnetsActuators including electromagnets

21.

MAGNETOMOTIVE STATOR SYSTEM AND METHODS FOR WIRELESS CONTROL OF MAGNETIC ROTORS

      
Application Number US2010055133
Publication Number 2011/053984
Status In Force
Filing Date 2010-11-02
Publication Date 2011-05-05
Owner PULSE THERAPEUTICS, INC. (USA)
Inventor
  • Creighton, Francis, M.
  • Ritter, Rogers, C.

Abstract

The present invention relates to a system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator. In one aspect, the invention relates to the control of magnetic particles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Examples of vascular occlusions targeted by the system include, but are not limited to, atherosclerotic plaques, including fibrous caps, fatty buildup, coronary occlusions, arterial stenosis, restenosis, vein thrombi, arterial thrombi, cerebral thrombi, embolisms, hemorrhages, other blood clots, and very small vessels.

IPC Classes  ?

  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body